Flexeril and Asacol hd drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Asacol hd (mesalamine). Common drug interactions include malaise among females and constipation among males.
The phase IV clinical study analyzes what interactions people have when they take Flexeril and Asacol hd. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
What is Asacol hd?
Asacol hd has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 985 Asacol hd users. Check the latest studies of Asacol hd.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
18 people who take Flexeril and Asacol hd together, and have interactions are studied.

What are the common drug interactions of Flexeril and Asacol Hd, by gender? *:
female:
- Malaise (a feeling of general discomfort or uneasiness)
- Nerve injury
- Pneumonia
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Rash
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Suicidal ideation
- Asthenia (weakness)
- Fatigue (feeling of tiredness)
male:
- Constipation
- Drug ineffective
What are the common drug interactions of Flexeril and Asacol Hd, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Asthenia (weakness)
- Drug ineffective
- Fatigue (feeling of tiredness)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
40-49:
n/a
50-59:
- Asthenia (weakness)
- Fatigue (feeling of tiredness)
- Fungal skin infection
- Injection site induration
- Injection site pain
- Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
- Pain
60+:
- Fall
- Pyrexia (fever)
- Drug hypersensitivity
- Weight decreased
- Ageusia (loss of taste functions of the tongue)
- Ankle fracture
- Asthenia (weakness)
- Brain injury
- Chest pain
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 44.44%
- Apnea (temporary absence or cessation of breathing): 5 people, 27.78%
- Pain: 3 people, 16.67%
- Depression: 3 people, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
- Colitis (inflammation of colon): 1 person, 5.56%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 5.56%
- Dyspnea (difficult or laboured breathing): 1 person, 5.56%
- Drowsiness: 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Flexeril and Asacol hd?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Flexeril and Asacol hd:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Asacol hd:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flexeril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Asacol hd and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and mesalamine (the active ingredients of Flexeril and Asacol hd, respectively), and Flexeril and Asacol hd (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Eliquis cause Enteritis? - 32 seconds ago
- Could Cialis cause Squamous Cell Carcinoma Of Skin? - 38 seconds ago
- Drug interactions of Topamax and Namenda - 42 seconds ago
- Could Tylenol cause Hoarseness Or Changing Voice? - 48 seconds ago
- Could Rebif cause Haemoglobin Increased? - 52 seconds ago
- Could Mirtazapine cause Swelling? - 52 seconds ago
- Vulvovaginal Pruritus and Vulvovaginal Burning Sensation - 52 seconds ago
- Could Remicade cause Idiopathic Or Primary Livedo Reticularis? - 53 seconds ago
- Could Rebetol cause Hyperkalemia? - 54 seconds ago
- Could Chromium cause General Physical Health Deterioration? - a minute ago